GNRH1 and cancer: Other options such as gonadal shielding, GnRH analogs are also offered to cancer-diagnosed patients, similar to developed countries.15 However, the fertility preservation referral rates are only about 4-12% even in European countries.16 In India, while there are no studies reporting referral rates, the number of patients receiving fertility preservation counselling is quite low.